4月28日早盘,港股医药板块大幅调整, 康方生物 暴跌,盘中一度跌超15%,恒生医药ETF(159892)一度跌超2%, 三生制药 、 再鼎医药 、亚盛医药等跌幅较大。消息面来看,康方生物合作伙伴Summit Therapeutics因依沃西OS数据未达预期,股价暴跌,市场担忧其商业化前景及对康方生物的里程碑付款能力,压制康方生物股价。此外,康方生物股价在近期因依沃西获批及派安普利美国上市消息连续...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.